TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
TVRD
55 hedge funds and large institutions have $44.9M invested in Tvardi Therapeutics, Inc. Common Stock in 2025 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 16 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
55
Holders Change
+22
Holders Change %
+66.67%
% of All Funds
0.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
16
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
SPC
Slate Path Capital
New York
|
+$16.4M |
2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.99M |
3 |
BlackRock
New York
|
+$5.77M |
4 |
6CM
683 Capital Management
New York
|
+$3.63M |
5 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.31M |